Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Medication withdrawal versus usual care in low-risk primary prevention patients treated for hypertension and/or hypercholesterolemia
NL-OMON39214Active, not recruiting
- Sponsor
- ZonMw
- Start
- Nov 2012
- Countries
- 1
01
Overview
Randomised, open-label trial in hypertension (HTN) and hypercholesterolemia (2 arms), sponsored by ZonMw. Primary endpoint: Change in 10-year cardiovascular disease risk. Started Nov 2012; status: active, not recruiting.
02
Conditions
hypertension (HTN)hypercholesterolemia
Beyond the preview
Go deeper on NL-OMON39214.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON39214.